Document is current
Any future updates will be listed below
-
Authors
Mantena, Sreekar https://orcid.org/0000-0002-8834-1461
Edahiro, Ryuya
Okada, Yukinori https://orcid.org/0000-0002-0311-8472
Akbari, Ali
Raychaudhuri, Soumya https://orcid.org/0000-0002-1901-8265
- License Information
-
More Information
Article History
Received: 17 October 2025
Accepted: 15 May 2026
First Online: 6 June 2026
Competing interests
: S.R. is a founder for Mestag, Inc, and serves as a scientific advisor for BMS, Janssen, Merck, Pfizer, Nimbus, and Bonito. The remaining authors declare no competing interest for this study.
